TROP2 correlates with microvessel density and poor prognosis in hilar cholangiocarcinoma. (Q46022447)

18 December 2017

title

TROP2 correlates with microvessel density and poor prognosis in hilar cholangiocarcinoma. (English)

1 reference

18 December 2017

0 references

1 reference

Shanglei Ning

1 reference

18 December 2017

Sen Guo

1 reference

18 December 2017

Jianjun Xie

1 reference

18 December 2017

Yunfei Xu

1 reference

18 December 2017

Xiaofei Lu

1 reference

18 December 2017

Yuxin Chen

1 reference

18 December 2017

language of work or name

1 reference

1 December 2012

1 reference

18 December 2017

Journal of Gastrointestinal Surgery

published in

1 reference

18 December 2017

volume

1 reference

18 December 2017

issue

1 reference

18 December 2017

page(s)

360-368

1 reference

18 December 2017

Surgical management and prognostic factors of hilar cholangiocarcinoma: experience with 115 cases in China

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-2105-1

Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-2105-1

Recurrence-free long-term survival after liver transplantation in patients with 18F-FDG non-avid hilar cholangiocarcinoma on PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-2105-1

Natural History and Prognostic Factors of Advanced Cholangiocarcinoma without Surgery, Chemotherapy, or Radiotherapy: A Large-Scale Observational Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-2105-1

Surgical management of cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-2105-1

Management of hilar cholangiocarcinoma in the North of England: pathology, treatment, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-2105-1

Photodynamic therapy is associated with an improvement in survival in patients with irresectable hilar cholangiocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-2105-1

Human trophoblast cell-surface antigens defined by monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-2105-1

High expression of TROP2 correlates with poor prognosis in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-2105-1

Clinical significance of TROP2 expression in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-2105-1

Identification of Trop-2 as an oncogene and an attractive therapeutic target in colon cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-2105-1

Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-2105-1

Potential hepatic stem cells reside in EpCAM+ cells of normal and injured mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-2105-1

Angiogenesis: an organizing principle for drug discovery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-2105-1

Angiogenesis in life, disease and medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-2105-1

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-2105-1

Prognostic relevance of tumour-associated macrophages and von Willebrand factor-positive microvessels in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-2105-1

Endoscopic management of hilar cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-2105-1

Burden of digestive diseases in the United States Part III: Liver, biliary tract, and pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-2105-1

Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-2105-1

The Trop-2 signalling network in cancer growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-2105-1

Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-2105-1

A bicistronic CYCLIN D1-TROP2 mRNA chimera demonstrates a novel oncogenic mechanism in human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-2105-1

Chimeric Trop2 virus-like particles: a potential immunotherapeutic approach against pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-2105-1

The emerging role of EpCAM in cancer and stem cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-2105-1

EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-2105-1

Specificity and properties of MAb RS7-3G11 and the antigen defined by this pancarcinoma monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-2105-1

Uterine serous papillary carcinomas overexpress human trophoblast-cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized anti-Trop-2 monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-2105-1

Preclinical therapy of breast cancer with a radioiodinated humanized anti-EGP-1 monoclonal antibody: advantage of a residualizing iodine radiolabel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-2105-1

TROP2 expression as prognostic marker for gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-2105-1

Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinomas

21 January 2018

1 reference

12 December 2020

Angiogenesis and clinicopathologic characteristics in different hepatocellular carcinoma subtypes defined by EpCAM and α-fetoprotein expression status

1 reference

12 December 2020

Liver resections for hilar cholangiocarcinoma.

1 reference

12 December 2020

1 reference

12 December 2020

Upregulation of Trop-2 quantitatively stimulates human cancer growth

1 reference

12 December 2020

TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavity

1 reference

12 December 2020

Microvessel density correlates with lymph node metastases and prognosis in hilar cholangiocarcinoma

1 reference

12 December 2020

Trop2: a possible therapeutic target for late stage epithelial carcinomas

1 reference

12 December 2020

Evaluation of VEGF A expression and microvascular density as prognostic factors in extrahepatic cholangiocarcinoma

1 reference

12 December 2020

Application of portal parenchyma-enterostomy after high hilar resection for Bismuth type IV hilar cholangiocarcinoma.

1 reference

12 December 2020

(-)-Epigallocatechin-3-gallate (EGCG) post-transcriptionally and post-translationally suppresses the cell proliferative protein TROP2 in human colorectal cancer cells

1 reference

12 December 2020

Epithelial cell polarity, stem cells and cancer

1 reference

12 December 2020

10.1007/S11605-012-2105-1

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017